ERBB2 and metastatic neoplasm: For patients with a history of HER2+ metastatic disease who present with symptomatic, newly diagnosed BM, upfront stereotactic radiosurgery (SRS) is a reasonable approach when technically feasible (and often preferred over whole brain radiotherapy [WBRT]) (REAL Alliance Expert opinion).